Matrix Metalloproteinases  by Fridman, Rafael
Biochimica et Biophysica Acta 1803 (2010) 1–2
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrPreface
Matrix MetalloproteinasesProteolysis is a fundamental aspect of life, starting from its beginning
to its inevitable end. Life, aswe know it, will not existwithout the action
of proteolytic enzymes, which cooperatively contribute to the evolution
and survival of all living organisms by altering the cellular proteome.
This special issue focuses on recent advances in a major group of
proteases, namely the matrix metalloproteinase (MMP) family of zinc-
dependent endopeptidases. Although traditionally viewed as extracel-
lular matrix (ECM) degrading proteases, the MMPs hydrolyze multiple
proteins at distinct subcellular and cellular sites and thereby inﬂuence
many biological processes in a highly regulated fashion. Controlled
MMP-dependent proteolysis is essential for the normal function of the
organism while deregulated MMP activity can lead to development of
disease. The importance of MMPs in the pathogenesis of cardiovascular
disease, neurological disease and cancer, just to mention a few, is
irrefutable. In recent years, there has been an exponential growth in our
knowledge of MMP function thanks to various technological advances
in structural biology, proteomics, degradomics, and animal models. We
have learned that theMMP family is not amonolithic group of proteases
but rather is comprised of structurally and functionally distinct
proteases, each with its unique spatial and temporal expression,
substrate proﬁle, and biological function. Advances in structural biology
provided exquisite insight into the structural features of MMP domains
and the mechanism of catalysis and inhibition at the atomic level.
Proteomic based approaches have considerably expanded the substrate
proﬁle of MMPs, revealing unexpected targets and biological functions.
Studies with genetically modiﬁed mice have revealed new roles for
MMPs in development and in various physiological and pathological
conditions.We have seen the emergence of new chemical and biological
approaches to MMP inhibition and the design of molecular beacons to
detect enzymatic activity in vivo. Collectively this new and vast
information has generated new concepts in MMP biology. It has also
helped to explain some of the reasons behind the failure of MMP
inhibitors in the clinical trials thatwere conducted during the 1980s and
1990s with cancer patients. There is no doubt that this knowledge and
the lessons learned from the early trials will contribute to the
development of novel and better strategies for targeting deregulated
MMP activity in disease conditions.
Current research into the function and regulation of MMPs
continues to generate new discoveries and also raises more questions.
This special issue of BBA-Molecular and Cell Research strives to
provide an overviewof someof the recent advances in theMMPﬁeld in
areas as diverse as structure, function, inhibition, and drug develop-
ment. The goal of these reviews is also to address controversial issues
and to serve as a forum to disclose new ideas and concepts on MMP
biology.With this inmind, this special issue of BBA-Molecular and Cell
Research was assembled with 11 scientiﬁc reviews from leading
investigators in various aspects of MMP research. This volume begins
with a review from Dr. Fanjul-Fernandez and her colleagues, which
provides a comprehensive and up-to-date overview of the MMP0167-4889/$ – see front matter © 2010 Published by Elsevier B.V.
doi:10.1016/j.bbamcr.2010.01.016family. The authors discuss MMP evolution, structure, and regulation
with emphasis on MMPs' biological role in human diseases and in
mouse transgenicmodels. A review fromDr. Tallant et al. provides new
insights into the structural determinants of the catalytic domains of
MMPs and their implication for drug design. Based on new disclosures
of MMP structure, allosteric regulation, and substrate interactions, Dr.
Sela and colleagues highlight the potential of MMP domains, other
than the active site, as new targets for inhibition of enzymatic activity.
The importance of deﬁning the substrate proﬁle of MMPs, referred to
as degradomics, is the topic of a review by Dr. Rodriguez et al. MMP
degradomics continues to be a challenging task, in particular in vivo,
that is at the core of deﬁning the physiological roles of MMPs. MMP-
dependent proteolysis is controlled by the action of their endogenous
inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). This
special issue includes a comprehensive and up-to-date review by Dr.
Brew and Dr. Nagase, which covers new ﬁndings on the structural
features and biological functions of TIMPs. Two reviews cover distinct
aspects of MMP inhibition; inhibitor design and the complexities of
targeting MMP activity in cancer as a targeted disease. Dr. Jacobsen et
al. discuss the pros and cons of different strategies under development
to block the catalytic center of MMPs with chemical inhibitors. Dr.
Kruger and his colleagues highlight the need to understand MMP
function within the context of proteolytic networks in cancer tissues
for achieving productive and therapeutic MMP inhibition. They also
discuss the potential consequences of speciﬁc vs. broad inhibition of
MMP activity for therapeutic efﬁcacy. A review by Dr. Deryugina and
Dr. Quigley discusses the complex roles that MMPs play in tumor
metastasis and angiogenesis. The authors highlight the diverse and
sometimes opposing actions that MMPs may elicit in cancer
progression and their potential impact on anti-MMP therapies. The
multifaceted biological consequences of metalloproteinase activity as
revealed in genetically modiﬁed mice is the topic of a review by Dr.
Aiken and Dr. Khokha focusing on skeletal tissue, as a model system.
This special issue concludes with two reviews focusing on MT1-MMP,
a member of the membrane type MMP subfamily. Dr. Alex Strongin's
review provides an overview on the structure, function and inhibition
ofMT1-MMP. It also covers emerging data on the interactions between
MT1-MMP and TIMP-2 and the consequences of these interactions for
proteolytic and non-proteolytic events. Finally, Dr. Gingras and Dr.
Beliveau describe new ﬁndings on the role of the cytoplasmic domain
of MT1-MMP, a unique structural feature of the transmembrane
MMPs, in regulation of enzyme function.
In spite of the many advances, we have only seen a glimpse of the
MMP world. There is much more ahead to be known about this
fascinating group of proteases. Through it we may began to
comprehend some of the mysteries of life as we perceive it. This
understanding will lead to the growth of scientiﬁc knowledge and the
well-being of humanity. I wholeheartedly thank the contributors for
their enlightening and scholarly reviews. A special thanks to the
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